Shiwen Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shiwen Guo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Gang Zhang
The Affiliated Children Hospital of Xi’an Jiaotong University, Xi’an, China
3 shared publicationsHangyu Shi
The Affiliated Children Hospital of Xi’an Jiaotong University, Xi’an, China
3 shared publicationsLin Wei
Xi’an Chest Hospital, Xi’an, China
3 shared publicationsLu Gao
The Affiliated Children Hospital of Xi’an Jiaotong University, Xi’an, China
3 shared publicationsNan Li
Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
3 shared publicationsNing Wang
Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
3 shared publications
Latest Publications
- 27 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 820, 153860
K777 promotes functional recovery after spinal cord injury via the PI3K/AKT signaling pathway
- 27 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 820, 153860
K777 promotes functional recovery after spinal cord injury via the PI3K/AKT signaling pathway
- 9 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 817, 153700
Scutellarein inhibits the malignancy of gliomas by modulating the PI3K/AKT signaling pathway
- 9 April 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 817, 153700
Scutellarein inhibits the malignancy of gliomas by modulating the PI3K/AKT signaling pathway
- 8 November 2021
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 22 (1) , 27-33
ARRDC3 polymorphisms may affect the risk of glioma in Chinese Han
This study ascertained to explore the potential contribution of ARRDC3 polymorphisms in the risk and prognosis of glioma. One thousand sixty-one patients and healthy controls were conducted to assess whether ARDC3 polymorphism was associated with glioma risk and prognosis. Four sites in ARRDC3 were selected and genotyped in MassARRAY platform. The calculated odd ratios and 95% confidence intervals from logistic regression were applied for risk assessment. The relationship between ARRDC3 variants and glioma prognosis was evaluated using log-rank test, Kaplan–Meier analysis, and so on. Also, false-positive report probability (FPRP) and statistical power were also assessed. Our findings suggested the negative role of ARRDC3 polymorphisms in the glioma risk. We also found the effect of candidate SNPs in ARRDC3 on the susceptibility to glioma was dependent on the age, gender, and histology of glioma patients. The results suggested that the genetic polymorphisms of ARRDC3 were related to an increased risk of glioma.
- 8 November 2021
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 22 (1) , 27-33
ARRDC3 polymorphisms may affect the risk of glioma in Chinese Han
This study ascertained to explore the potential contribution of ARRDC3 polymorphisms in the risk and prognosis of glioma. One thousand sixty-one patients and healthy controls were conducted to assess whether ARDC3 polymorphism was associated with glioma risk and prognosis. Four sites in ARRDC3 were selected and genotyped in MassARRAY platform. The calculated odd ratios and 95% confidence intervals from logistic regression were applied for risk assessment. The relationship between ARRDC3 variants and glioma prognosis was evaluated using log-rank test, Kaplan–Meier analysis, and so on. Also, false-positive report probability (FPRP) and statistical power were also assessed. Our findings suggested the negative role of ARRDC3 polymorphisms in the glioma risk. We also found the effect of candidate SNPs in ARRDC3 on the susceptibility to glioma was dependent on the age, gender, and histology of glioma patients. The results suggested that the genetic polymorphisms of ARRDC3 were related to an increased risk of glioma.
- 28 July 2021
- Published by Wiley in International Journal of Cancer
- Vol. 149 (11) , 1910-1915
Genetic variants of CYP4F12 gene are associated with glioma susceptibility
Glioma is a common and fatal primary malignant tumor of the central nervous system, and its prognosis is poor. To determine the susceptibility markers of gliomas in Chinese population we conducted a genome‐wide association study (GWAS) of glioma in the Han Chinese population, with a total of 485 glioma cases and 485 controls. Genotyping was conducted using the Applied Biosystems Axiom Precision Medicine Diversity Array. Besides, we carried out imputation using IMPUTE 2.0 software, and the 1000 Genomes Phase 3 was used as the reference panel. The logistic regression model was used to analyze the association of each SNP with glioma risk, assuming an additive genetic model, which was implemented in PLINK version 1.9. Odds ratio (OR) and 95% confidence interval (CI) were estimated from logistic regression analysis with adjustment for age and gender. The results revealed that the SNP (rs688755) in the exon region of CYP4F12 at 19p13.12 reached genome‐wide significance associated with gliomas (P = 2.35 × 10−8, OR = 3.55, 95% CI = 2.20‐5.74). Our findings provide deeper insight into the genetic contribution to glioma in different populations.
- 28 July 2021
- Published by Wiley in International Journal of Cancer
- Vol. 149 (11) , 1910-1915
Genetic variants of CYP4F12 gene are associated with glioma susceptibility
Glioma is a common and fatal primary malignant tumor of the central nervous system, and its prognosis is poor. To determine the susceptibility markers of gliomas in Chinese population we conducted a genome‐wide association study (GWAS) of glioma in the Han Chinese population, with a total of 485 glioma cases and 485 controls. Genotyping was conducted using the Applied Biosystems Axiom Precision Medicine Diversity Array. Besides, we carried out imputation using IMPUTE 2.0 software, and the 1000 Genomes Phase 3 was used as the reference panel. The logistic regression model was used to analyze the association of each SNP with glioma risk, assuming an additive genetic model, which was implemented in PLINK version 1.9. Odds ratio (OR) and 95% confidence interval (CI) were estimated from logistic regression analysis with adjustment for age and gender. The results revealed that the SNP (rs688755) in the exon region of CYP4F12 at 19p13.12 reached genome‐wide significance associated with gliomas (P = 2.35 × 10−8, OR = 3.55, 95% CI = 2.20‐5.74). Our findings provide deeper insight into the genetic contribution to glioma in different populations.
- Open Access
- 5 April 2021
- Published by Springer Nature in Research Square
The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population
Background: glioma is a highly fatal malignant tumor with a high recurrence rate. We aimed to determine the association between single nucleotide polymorphisms (SNPs) of NDRG1 and glioma risk and prognosis in the Chinese Han population. Methods: 5 candidate SNPs were genotyped by Agena MassARRAY; logistic regression was used to analyze the association between SNPs and glioma risk; We used multi-factor dimensionality reduction to analyze the interaction of ‘SNP-SNP’; the prognosis analysis was performed by log-rank test, Kaplan–Meier analysis and Cox regression model. Results: our results showed that the rs3808599 was associated with the reduction of glioma risk in all participants (p = 0.024) and the participants ≤40 years old (p = 0.020). rs3802251 may reduce glioma risk in all participants (p = 0.008), the male (p = 0.033) or astrocytoma patients (p = 0.023). rs3779941 was associated with poor glioma prognosis in the all participants (p = 0.039) or astrocytoma patients (p = 0.038). We also found that the key factors for glioma prognosis may include surgical operation, radiotherapy and chemotherapy. Conclusion: this study is the first to find that NDRG1 gene polymorphisms may have a certain association with glioma risk or prognosis in the Chinese Han population.
- 5 April 2021
- Published by Springer Nature in Research Square
Open AccessThe Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population
Background: glioma is a highly fatal malignant tumor with a high recurrence rate. We aimed to determine the association between single nucleotide polymorphisms (SNPs) of NDRG1 and glioma risk and prognosis in the Chinese Han population. Methods: 5 candidate SNPs were genotyped by Agena MassARRAY; logistic regression was used to analyze the association between SNPs and glioma risk; We used multi-factor dimensionality reduction to analyze the interaction of ‘SNP-SNP’; the prognosis analysis was performed by log-rank test, Kaplan–Meier analysis and Cox regression model. Results: our results showed that the rs3808599 was associated with the reduction of glioma risk in all participants (p = 0.024) and the participants ≤40 years old (p = 0.020). rs3802251 may reduce glioma risk in all participants (p = 0.008), the male (p = 0.033) or astrocytoma patients (p = 0.023). rs3779941 was associated with poor glioma prognosis in the all participants (p = 0.039) or astrocytoma patients (p = 0.038). We also found that the key factors for glioma prognosis may include surgical operation, radiotherapy and chemotherapy. Conclusion: this study is the first to find that NDRG1 gene polymorphisms may have a certain association with glioma risk or prognosis in the Chinese Han population.